High-grade serous ovarian cancer (HGSOC) accounts for 70–80% of ovarian cancer deaths,
and overall survival has not changed significantly for several decades. In this Opinion article …

Ovarian cancer is the third most common gynaecological malignancy and the most lethal
worldwide. Most patients are diagnosed with advanced disease which carries significant …

Introduction: Despite advances in surgery and chemotherapy for ovarian cancer, 70% of
women still succumb to the disease. Biomarkers have contributed to the management of …

Abstract Purpose of Review Both conventional and novel approaches to early detection of
ovarian cancer are reviewed in the context of new developments in our understanding of …

Evidence of a mortality benefit continues to elude ovarian cancer (OC) screening. Data from
the US Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial which used a …

White light endoscopic imaging allows for the examination of internal human organs and is
essential in the detection and treatment of early-stage cancers. To facilitate diagnosis of …

A novel origin for pelvic serous cancer (ovarian cancer) has been proposed in the distal
oviduct. This has important implications, including both early detection in high-risk women …

Since 2001, many studies by different investigators have demonstrated that the fallopian
tube might be at the origin of most high-grade ovarian and peritoneal serous carcinomas …

Early detection of ovarian cancer is only achieved in around 20% of women due to lack of
effective screening. We propose a method for surveillance of high risk women based on a …

Introduction: Serous tubal intraepithelial carcinoma (STIC) is most likely precursor lesion of
the most part of high-grade serous pelvis carcinomas, carcinosarcoma and undifferentiated …